332 Peginterferon alfa-2A (40KD) (PEGASYS®) in combination with ribavirin in African American and Caucasian patients with chronic hepatitis C HCV genotype 1: safety and tolerability

Author(s):

C HOWELL ◽

L JEFFERS ◽

W CASSIDY ◽

K RAJENDERREDDY ◽

S SHERIDAN ◽

...

Keyword(s):

African American ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Hcv Genotype ◽

Caucasian Patients ◽

Hcv Genotype 1 ◽

Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population

Journal of Viral Hepatitis ◽

10.1111/j.1365-2893.2009.01157.x ◽

2010 ◽

Vol 17 (2) ◽

pp. 139-147 ◽

Cited By ~ 22

Author(s):

M. Rodriguez-Torres ◽

M. S. Sulkowski ◽

R. T. Chung ◽

F. M. Hamzeh ◽

D. M. Jensen

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Virologic Response ◽

Genotype 1 ◽

Early Virologic Response ◽

Hcv Genotype ◽

Factors Associated ◽

Hcv Genotype 1 ◽

328 Comparison of 48 or 72 weeks of treatment with peginterferon alfa-2A (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in treatment-naive patients with chronic hepatitis C infected with HCV genotype 1

Hepatology ◽

10.1016/s0270-9139(03)80371-3 ◽

2003 ◽

Vol 38 ◽

pp. 317-317 ◽

Cited By ~ 6

Author(s):

T BERG ◽

M VONWAGNER ◽

H HINRICHSEN ◽

T HEINTGES ◽

P BUGGISCH ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Hcv Genotype ◽

Treatment Naïve ◽

Hcv Genotype 1 ◽

P1167 rs12979860 IL28B GENOTYPE IS ASSOCIATED WITH ADVANCED FIBROSIS IN HCV GENOTYPE 1-INFECTED EUROPEAN PATIENTS WITH CHRONIC HEPATITIS C: RESULTS FROM THE INTERNATIONAL GEN-C STUDY

Journal of Hepatology ◽

10.1016/s0168-8278(14)61327-1 ◽

2014 ◽

Vol 60 (1) ◽

pp. S473

Author(s):

A. Mangia ◽

V. De Ledinghen ◽

F. Bailly ◽

J. Brahm ◽

J. Keiss ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Il28b Genotype ◽

Advanced Fibrosis ◽

Genotype 1 ◽

Hcv Genotype ◽

Hcv Genotype 1

The pharmacokinetics of peginterferon alfa-2a and ribavirin in African American, Hispanic and Caucasian patients with chronic hepatitis C

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2012.05079.x ◽

2012 ◽

Vol 35 (10) ◽

pp. 1209-1220 ◽

Cited By ~ 7

Author(s):

B. J. Brennan ◽

P. N. Morcos ◽

K. Wang ◽

S. D. Blotner ◽

R. Morrison ◽

...

Keyword(s):

African American ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Caucasian Patients ◽

71 Peginterferon Alfa-2A (40KD) (PEGASYS®) in combination with ribavirin in African American and caucasian patients with chronic hepatitis C virus genotype 1: results of a multicenter study

Hepatology ◽

10.1016/s0270-9139(03)80114-3 ◽

2003 ◽

Vol 38 ◽

pp. 190-190 ◽

Author(s):

L JEFFERS ◽

W CASSIDY ◽

C HOWELL ◽

K RAJENDERREDDY ◽

S SHERIDAN ◽

...

Keyword(s):

African American ◽

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Multicenter Study ◽

Genotype 1 ◽

Virus Genotype ◽

Chronic Hepatitis C Virus ◽

Caucasian Patients ◽

The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1

Journal of Viral Hepatitis ◽

10.1111/jvh.12289 ◽

2014 ◽

Vol 22 (3) ◽

pp. 254-262 ◽

Cited By ~ 6

Author(s):

T. Oze ◽

N. Hiramatsu ◽

T. Yakushijin ◽

R. Yamada ◽

N. Harada ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Side Effects ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Genotype 1 ◽

Hcv Genotype ◽

The Real ◽

Hcv Genotype 1 ◽

Chronic Hepatitis C Patients

307 Peginterferon alfa-2A (40KD) (PEGASYS®) in combination with ribavirin in African American and Caucasian patients with chronic hepatitis C virus genotype 1 infection: Assessment of histologic response

Hepatology ◽

10.1016/s0270-9139(03)80350-6 ◽

2003 ◽

Vol 38 ◽

pp. 303-303 ◽

Author(s):

W CASSIDY ◽

L JEFFERS ◽

C HOWELL ◽

K RAJENDERREDDY ◽

S SHERIDAN ◽

...

Keyword(s):

African American ◽

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Genotype 1 ◽

Virus Genotype ◽

Histologic Response ◽

Chronic Hepatitis C Virus ◽

Caucasian Patients ◽

Long-Term Outcomes of Ledipasvir/Sofosbuvir (LDV/ SOF) for the Treatment of Chronic Hepatitis C Infected (HCV) Genotype 1 Patients in the UK

Value in Health ◽

10.1016/j.jval.2014.08.2507 ◽

2014 ◽

Vol 17 (7) ◽

pp. A675

Author(s):

I. Guerra ◽

L. Marie ◽

S. Cure

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Long Term Outcomes ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

The Uk

Cost-Effectiveness Of Boceprevir Therapy In Adult Patients With Chronic Hepatitis C (Hcv) Genotype 1

Value in Health ◽

10.1016/j.jval.2013.03.440 ◽

2013 ◽

Vol 16 (3) ◽

pp. A94 ◽

Author(s):

P. Mernagh ◽

J. Feng ◽

M Del Cuore

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Adult Patients ◽

Genotype 1 ◽

Hcv Genotype ◽

Hcv Genotype 1

SAFETY OF OMBITASVIR/PARITAPREVIR/RITONAVIR+DASABUVIR IN CHRONIC HEPATITIS C PATIENTS WITH HCV GENOTYPE 1 INFECTION

Acta Poloniae Pharmaceutica - Drug Research ◽

10.32383/appdr/105681 ◽

2019 ◽

Vol 76 (4) ◽

pp. 613-620

Author(s):

Tomasz Tatara ◽

Marta Dąbrowska-Bender ◽

Anna Staniszewska ◽

Aneta Duda-Zalewska

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Chronic Hepatitis C Patients